Skip to content
Canadian orders above $200 ship free · Dispatched from Canadian stock

NAD+ side effects and results in studies

Every statement is bound to the study that reported it. Tolerability observations from the cited papers appear below in the authors own terms. Human research on this scale cannot establish a safety profile.

Adverse events reported

EventAs reportedSource
NR was well tolerated and gave a significant but variable rise in brain NAD measured by 31P-MRS, altered cerebral metabolism on FDG-PET in those whose brain NAD rose, and lowered inflammatory cytokines in serum and cerebrospinal fluid.HumanBrakedal B et al.
Pulse wave velocity tended to fall but did not differ significantly from placebo; no adverse events were reported.HumanKatayoshi T et al.
Chronic NR was well tolerated and stimulated NAD+ metabolism; the authors suggest blood pressure and arterial stiffness as outcomes for future trials.HumanMartens CR et al.

Outcomes measured

No outcome data are tabulated yet.

What the studies don't show

None of it applies beyond the trial protocol itself. Testing establishes identity and purity; it is not evidence of an effect.